Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome

J Coll Physicians Surg Pak. 2005 Jun;15(6):329-32.

Abstract

Objective: To determine the efficacy of three different treatment protocols in steroid resistant idiopathic nephrotic syndrome, (SRINS).

Design: Interventional study.

Place and duration of study: Department of Nephrology at The Children's Hospital, Lahore, over a period of 3 years from January 2000 to December 2002.

Patients and methods: Nephrotic children who did not respond to four weeks of steroid therapy (60mg/M2) followed by three pulses of methyl prednisolone (1Gm/1.73M2) over a period of one week were labeled as steroid resistant. Those with histopathological lesions of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS) and Mes.PGN were divided into 3 groups. Group-I was treated with cyclophosphamide (CPM) and oral steroids, group-II with cyclosporine and oral steroids and group-III with pulse methyl prednisolone (MPP) and oral steroid + CPM. The response to treatment and course of disease were observed in each group.

Results: Twenty patients with mean age of 4.4 years were enrolled. On the whole 10 (50%) had complete remission. In group-I, 5 (50%), in group-II, 3 (75%) and in group-III, 2 (33.3%) had complete remission. Depending upon histological lesion 100% (n=2) with MCD, 50% (n=6) with Mes.PGN and 25% (n=1) with FSGS achieved complete remission. Cyclosporine and CPM induced remission in 100% of patients with MCD, while in Mes.PGN response rate in group-I, II, and III was 100% (n=1), 50%(n=1), and 44.4%(n=4) respectively. In patients with FSGS, MPP was the only drug used with limited response of 25% (n=1).

Conclusion: Cyclosporine proved to be a better option for MCD and Mes.PGN, while MPP showed limited response in patients with FSGS.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adolescent
  • Biopsy
  • Child
  • Child, Preschool
  • Cyclophosphamide / therapeutic use*
  • Cyclosporine / therapeutic use*
  • Drug Resistance*
  • Female
  • Follow-Up Studies
  • Glucocorticoids / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Male
  • Methylprednisolone / therapeutic use*
  • Nephrotic Syndrome / drug therapy*
  • Nephrotic Syndrome / pathology
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclosporine
  • Cyclophosphamide
  • Methylprednisolone